In a study of 109 triple negative breast cancer patients whose primary breast tumor was evaluated for GAL‐9+ immune cells, the authors found high GAL‐9 was significantly associated with higher levels of stromal TILs, PD‐L1 positive tumor cells and negative PD‐L1 immune cells. The gene discussed is LGALS9; the disease is breast neoplasm.